ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Mirena Extension Trial

ClinicalTrials.gov ID: NCT02985541

Public ClinicalTrials.gov record NCT02985541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Open-label, Uncontrolled Study to Assess Contraceptive Efficacy and Safety of Mirena During Extended Use Beyond 5 Years in Women 18 to 35 Years of Age Including a Subgroup Evaluation of Treatment Effect on Heavy Menstrual Bleeding

Study identification

NCT ID
NCT02985541
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
364 participants

Conditions and interventions

Conditions

Interventions

  • Levonorgestrel IUS (Mirena, BAY86-5028) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 35 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2016
Primary completion
May 27, 2021
Completion
May 27, 2021
Last update posted
Apr 27, 2022

2016 – 2021

United States locations

U.S. sites
49
U.S. states
25
U.S. cities
47
Facility City State ZIP Site status
Not listed Mobile Alabama 36608-6703
Not listed Phoenix Arizona 85032
Not listed Scottsdale Arizona 85251
Not listed Tucson Arizona 85712
Not listed Encinitas California 92024
Not listed San Francisco California 94110
Not listed Ventura California 93003
Not listed Aurora Colorado 80045
Not listed Atlanta Georgia 30342
Not listed Idaho Falls Idaho 83404
Not listed Fort Wayne Indiana 46825
Not listed Newburgh Indiana 47630-8940
Not listed Frederick Maryland 21702
Not listed Pikesville Maryland 21208
Not listed Boston Massachusetts 02118
Not listed Saginaw Michigan 48604
Not listed Lincoln Nebraska 68510
Not listed Las Vegas Nevada 89106
Not listed Lebanon New Hampshire 03756-1000
Not listed Lawrenceville New Jersey 08648
Not listed Neptune City New Jersey 07753
Not listed Albuquerque New Mexico 87109
Not listed New York New York 10032
Not listed Port Jefferson New York 11777
Not listed Asheville North Carolina 28801
Not listed Durham North Carolina 27713
Not listed Greensboro North Carolina 27408
Not listed Hickory North Carolina 28602
Not listed Morehead City North Carolina 28557
Not listed New Bern North Carolina 28562
Not listed Winston-Salem North Carolina 27103-1749
Not listed Franklin Ohio 45005-2593
Not listed Mayfield Heights Ohio 44124
Not listed Portland Oregon 97239
Not listed Erie Pennsylvania 16507
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Not listed Chattanooga Tennessee 37404
Not listed Austin Texas 78758
Not listed Fort Worth Texas 76104-4145
Not listed Houston Texas 77030
Not listed Draper Utah 84020-7163
Not listed Midlothian Virginia 23114
Not listed North Chesterfield Virginia 23235
Not listed Roanoke Virginia 24013-2256
Not listed Virginia Beach Virginia 23456
Not listed Seattle Washington 98105
Not listed Seattle Washington 98122
Not listed Spokane Washington 99207-1240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02985541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02985541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →